Histological detection of oxLDL involves immunohistochemistry using antibodies that specifically recognize oxidized epitopes of LDL. These techniques can be used to localize oxLDL within atherosclerotic plaques. Co-localization studies with other markers, such as macrophage markers (CD68) and endothelial markers (CD31), can provide insights into the cellular interactions and distribution of oxLDL within the tissue.
